Whole-body diffusion weighted MR and FDG-PET/CT in Hodgkin lymphoma: predictive role before treatment and early assessment aftrer two courses of chemotheraphy

Research output: Contribution to conferenceOther

Abstract

To evaluate whether whole-body MR has a predictive role before treatment and may asses the response after two courses of chemotherapy in comparison to FDG-PET/CT
Original languageEnglish
Number of pages1
Publication statusPublished - 2017

Fingerprint

Equidae
Hodgkin Disease
Drug Therapy
Therapeutics

Cite this

@conference{c86a5da7d16e4121945728eb6d4021b1,
title = "Whole-body diffusion weighted MR and FDG-PET/CT in Hodgkin lymphoma: predictive role before treatment and early assessment aftrer two courses of chemotheraphy",
abstract = "To evaluate whether whole-body MR has a predictive role before treatment and may asses the response after two courses of chemotherapy in comparison to FDG-PET/CT",
keywords = "MR-Diffusion/Perfusion, PET-CT, lymphoma",
author = "Roberto Lagalla and Massimo Galia and {La Grutta}, Ludovico and Domenica Matranga and Massimo Midiri",
year = "2017",
language = "English",

}

TY - CONF

T1 - Whole-body diffusion weighted MR and FDG-PET/CT in Hodgkin lymphoma: predictive role before treatment and early assessment aftrer two courses of chemotheraphy

AU - Lagalla, Roberto

AU - Galia, Massimo

AU - La Grutta, Ludovico

AU - Matranga, Domenica

AU - Midiri, Massimo

PY - 2017

Y1 - 2017

N2 - To evaluate whether whole-body MR has a predictive role before treatment and may asses the response after two courses of chemotherapy in comparison to FDG-PET/CT

AB - To evaluate whether whole-body MR has a predictive role before treatment and may asses the response after two courses of chemotherapy in comparison to FDG-PET/CT

KW - MR-Diffusion/Perfusion

KW - PET-CT

KW - lymphoma

UR - http://hdl.handle.net/10447/235632

UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321634/

M3 - Other

ER -